We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+11.8%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$804M
AUM Growth
-$172M
(-18%)
Cap. Flow
-$244M
Cap. Flow
% of AUM
-30.33%
Top 10 Holdings %
Top 10 Hldgs %
59.25%
Holding
273
New
116
Increased
49
Reduced
44
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$9.36M |
| 2 |
Assurant
AIZ
|
+$8.7M |
| 3 |
Allstate
ALL
|
+$7.12M |
| 4 |
Old Republic International
ORI
|
+$6.43M |
| 5 |
Thomson Reuters
TRI
|
+$5.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$349M |
| 2 |
Northern Trust
NTRS
|
+$10.2M |
| 3 |
T. Rowe Price
TROW
|
+$8.12M |
| 4 |
Raymond James Financial
RJF
|
+$7.49M |
| 5 |
Ameriprise Financial
AMP
|
+$6.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.57% |
| 2 | Financials | 16.5% |
| 3 | Industrials | 6.66% |
| 4 | Real Estate | 6.32% |
| 5 | Technology | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
126
DELISTED
Cerner Corp
CERN
| $1.22M | 0.15% |
+21,000
| New | +$1.36M |
|
127
Element Solutions
ESI
$8.95B
| $1.21M | 0.15% |
125,727
-6,087
| -5% | -$65K |
|
128
Astronics
ATRO
$3.43B
| $1.19M | 0.15% |
+43,906
| New | +$1.31M |
|
|
JNPR
129
DELISTED
Juniper Networks
JNPR
| $1.18M | 0.15% |
48,650
+28,650
| +143% | +$762K |
|
|
ADMS
130
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.17M | 0.15% |
+48,894
| New | +$1.54M |
|
131
Applied Materials
AMAT
$403B
| $1.17M | 0.15% |
21,000
-7,000
| -25% | -$390K |
|
|
DERM
132
DELISTED
Dermira, Inc.
DERM
| $1.17M | 0.14% |
+145,785
| New | +$3.17M |
|
133
Advanced Micro Devices
AMD
$776B
| $1.15M | 0.14% |
113,965
+83,965
| +280% | +$996K |
|
|
CLSD
134
DELISTED
Clearside Biomedical
CLSD
| $1.15M | 0.14% |
+7,111
| New | +$866K |
|
135
Ionis Pharmaceuticals
IONS
$8.6B
| $1.13M | 0.14% |
25,553
+27
| +0.1% | +$1.37K |
|
|
FOMX
136
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.12M | 0.14% |
217,670
+44,169
| +25% | +$266K |
|
|
REVG
137
DELISTED
REV Group
REVG
| $1.11M | 0.14% |
+53,637
| New | +$1.46M |
|
138
Healthpeak Properties
DOC
$15.1B
| $1.11M | 0.14% |
+47,771
| New | +$1.11M |
|
139
Rigel Pharmaceuticals
RIGL
$681M
| $1.1M | 0.14% |
31,039
-7,381
| -19% | -$295K |
|
|
NPKI
140
NPK International
NPKI
$1.06B
| $1.1M | 0.14% |
135,355
+110,763
| +450% | +$970K |
|
141
PepsiCo
PEP
$190B
| $1.09M | 0.14% |
+10,000
| New | +$1.14M |
|
142
Welltower
WELL
$169B
| $1.09M | 0.14% |
+20,032
| New | +$1.13M |
|
143
Coherent
COHR
$51.4B
| $1.08M | 0.13% |
+26,407
| New | +$1.14M |
|
144
Powell Industries
POWL
$7.6B
| $1.07M | 0.13% |
+119,670
| New | +$1.17M |
|
|
CPRX
145
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.07M | 0.13% |
446,702
+179,590
| +67% | +$597K |
|
146
National Health Investors
NHI
$3.72B
| $1.06M | 0.13% |
+15,794
| New | +$1.08M |
|
147
Take-Two Interactive
TTWO
$45.4B
| $1.05M | 0.13% |
+10,700
| New | +$1.2M |
|
148
STAG Industrial
STAG
$7.38B
| $1.02M | 0.13% |
+42,636
| New | +$1.04M |
|
|
HDS
149
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.02M | 0.13% |
26,865
+13,973
| +108% | +$526K |
|
150
MediciNova
MNOV
$65.5M
| $1.01M | 0.13% |
+99,206
| New | +$988K |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2018 Portfolio in Review
As of Q1 2018, Crestline Management held 273 positions worth $804M, down 18% from $976M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Crestline Management withdrew a net $244M in Q1 2018, closing 63 positions and reducing 44 holdings. Its most notable exit was Juno Therapeutics, Inc., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 38% a quarter earlier, followed by Financials and Industrials.
Against the trend, Crestline Management opened a new position in Principal Financial Group worth $8.66M.
- Crestline Management's largest Q1 2018 buy was Principal Financial Group: 142,238 shares worth $8.66M.
- Crestline Management added most to Old Republic International in Q1 2018, an estimated $6.43M increase.
- Crestline Management's biggest Q1 2018 reduction was Ameriprise Financial, cutting an estimated $6.18M.
- Crestline Management fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $349M.
- Crestline Management's ten largest holdings make up 59% of its $804M portfolio in Q1 2018.
- Crestline Management opened 116 new positions and closed 63 in Q1 2018.
- Crestline Management's portfolio value fell 18% quarter-over-quarter to $804M.
Based on Crestline Management's 13F filing for Q1 2018, filed 15 May 2018.